ReShape Lifesciences Inc.
RSLS
$0.6355
$0.00050.08%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.07M | -9.02M | -10.92M | -11.39M | -26.16M |
| Total Depreciation and Amortization | 24.00K | 69.00K | 112.00K | 154.00K | 662.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -108.00K | 552.00K | 468.00K | -1.59M | 10.52M |
| Change in Net Operating Assets | 954.00K | -267.00K | -3.63M | -4.13M | -2.35M |
| Cash from Operations | -6.20M | -8.67M | -13.97M | -16.96M | -17.33M |
| Capital Expenditure | 0.00 | 0.00 | -36.00K | -43.00K | -122.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 33.00K | 33.00K | 33.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -3.00K | -10.00K | -89.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.15M | 5.15M | 7.37M | 17.57M | 13.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 338.00K | 0.00 | 0.00 | 0.00 | -338.00K |
| Cash from Financing | 5.49M | 5.15M | 7.37M | 17.57M | 12.75M |
| Foreign Exchange rate Adjustments | 6.00K | 5.00K | -3.00K | 0.00 | -26.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -706.00K | -3.51M | -6.60M | 604.00K | -4.70M |
